Pith.

Analysis of PDEs · arXiv:2610.35763 v1 · submitted 26 Oct 2026 · 47 references

Existence and uniqueness of solutions for a random PDE-ODE model describing glioma invasion and radiotherapy

Martina Conte, Sandesh Athni Hiremath, Christina Surulescu

The paper says

“We study a stochastic model for the growth and invasion of glioma cells in the anisotropic brain tissue, also incorporating effects of radiotherapeutic interventions and associated uncertainties.”

more of the abstract

The PDE-ODE model couples glioma and healthy tissue dynamics in a nonlinear manner and explicitly includes treatment-related stochasticity through random depletion terms. The macroscopic system has been obtained by an upscaling procedure from a microscopic description in [1]. We prove the existence and uniqueness of local strong solutions to the corresponding stochastic system. The analysis addresses challenges arising from the nonlinear coupling, anisotropic diffusion, taxis mechanisms, and stochastic treatment effects, providing a first rigorous step toward the mathematical understanding of stochastic continuum models for glioma invasion and therapy response.

from the abstract

Pith says

Machine review · deepseek-v4-flash · 27 Oct 2026 · what was read was not recorded · not checked by a person

It can be wrong. Challenge this review or reply to it.

Holds up, with conditions. A credible local well-posedness proof for the stochastic glioma model, but only under assumptions that quietly reduce the advertised anisotropic DTI setting to homogeneous isotropic diffusion. This line is wrong

3 major objections · 3 minor

How often objections from reviews like this one are right: not yet measured

Are you an author? What you can do.

Not checked: figures, code, what the 47 references say.

The paper says, at Assumption II.2 / II.6, §3.2, Theorem 3.2

The review did not quote this passage.

Pith says: Objection 1 of 3 · major

Assumption II.2 contains the inequality |γ_1^T D_M(x) γ_0| < M̃_D |γ_1·γ_0| for all γ_1, γ_0 ∈ R^n. Read literally, choosing γ_1 ⊥ γ_0 makes the right-hand side zero, so γ_1^T D_M(x) γ_0 = 0 for every orthogonal pair. Taking γ_1 = e_i + e_j and γ_0 = e_i - e_j then forces the diagonal entries to coincide, so D_M(x) = c(x) I.

more of objection 1

Together with Assumption II.6 (D_1 = 0), the theorem as stated covers only constant isotropic diffusion, not the DTI-derived anisotropic tensors advertised in the abstract and in Section 1. If the dot product is a typo for |γ_1||γ_0|, the authors should correct it and re-examine the remaining D_1 = 0 restriction; as written, the scope of Theorem 3.2 does not match the motivating model (1).

The paper says, at §3.4, Eq. (20b), Assumption II.6

The review did not quote this passage.

A classifier read this sentence of the paper as acknowledging the concern (probability 0.70):

“In order to ensure the boundary condition for (2a) we make the following assumptions forD 1,v 0 andR Q: D1 = 0, ν·(gD M ∇v0) = 0 andν·(gD M ∇RQ) = 0 on∂D.”

Pith says: Objection 2 of 3 · major

The model (2a) imposes the total no-flux condition (D_1 u + D_0∇u)·ν = 0 on the boundary, but the abstract operator A(w,v) in (20b) has domain defined by ν·(D_0(w,v)∇u) = 0, while the term ∇·(D_1 u) is placed in the semilinear map F.

more of objection 2

The authors acknowledge in Assumption II.6 that D_1 = 0 is imposed 'in order to ensure the boundary condition for (2a)'. The unresolved consequence is that D_1 = ∇·D_M is generally nonzero for spatially varying DTI-derived tensors, so Theorem 3.2 does not cover the original anisotropic model. The statement should explicitly identify the theorem's scope as divergence-free D_M, or the proof should be extended to the case D_1 ≠ 0.

The paper says, at Lemma 3.11(ii), after Eq. (40)

The review did not quote this passage.

Pith says: Objection 3 of 3 · major

The contraction proof for the fixed-point map Φ is not complete as written. After deriving the X(T)-contraction estimate, the text states that 'the same estimates also control ∥U_1 − U_2∥_{L^p(Ω;Z^2_p)}' and concludes contractivity in the Y(T)-norm. The W^{2,p}-component is part of the Y(T)-norm on which the Banach fixed-point argument is performed, so this step is load-bearing. A displayed estimate for the Z^2_p(T) component of U_1 − U_2 is needed before the contraction claim is established.

3 minor objections

The paper says, at Definition 2.1 vs Assumption II.2

Pith says: minor objection 1 of 3

The notation for D_1 is inconsistent: Definition 2.1 sets D_1 := ∇·D_M, which is a vector field, whereas Assumption II.2 displays D_1 as an n^2×n matrix of first derivatives of the entries of D_M. The subsequent estimates in Lemma 3.7 treat the divergence form, so the assumption should be rewritten with notation matching the operator actually estimated.

The paper says, at Throughout, typographical issues

Pith says: minor objection 2 of 3

There are numerous minor typographical issues, including 'inequalites' in Corollary A.1, the garbled rendering of Itô's formula in Remark 2.1, and stray symbols in displayed formulas such as the '˜ map' in Appendix A.5. A careful proofreading pass is needed.

show 1 more

The paper says, at Theorem 3.2, nonnegativity step

Pith says: minor objection 3 of 3

The final nonnegativity proof invokes the invariant-set method without giving the comparison argument for the stochastic, non-autonomous setting. This is likely standard, but a short justification or reference would make the claim easier to verify.

What would settle it

One decisive check: take a non-isotropic symmetric tensor, e.g. D_M = R diag(2,1,1) R^T with R a rotation, and choose orthonormal vectors γ_1,γ_0 such that γ_1^T D_M γ_0 ≠ 0 (for a 45-degree rotation in the 1-2 plane, e_1^T D_M e_2 = 1/2 while e_1·e_2 = 0). This immediately violates II.2 as written, showing that the assumption excludes every anisotropic tensor. Separately, evaluate ∇·D_M for a DTI-derived tensor from the companion data; if it is nonzero, Assumption II.6 fails. To test the boundary step, verify whether the fixed-point solution's total flux (D_1 u + D_0∇u − g D_M ∇v)·ν vanishes on ∂D when D_1 ≠ 0; if not, the abstract solution does not solve (2a) in the stated sense.

from the skeptic's reading

How the review went

4 readings by deepseek-v4-flash · 27 Oct 2026

  1. Reader holds up, with conditions confidence moderate
  2. Skeptic partly agrees 3 min 55 s · 48,349 tokens read, 31,288 written
  3. Editor wrote the verdict above 41 s · 49,298 tokens read, 4,168 written
  4. Referee major revision: 3 major objections, 3 minor 1 min 40 s · 48,765 tokens read, 11,146 written

Not run on this paper: the simulated authors' defence.

Pith did not check this review's objections against the paper.

The review in full

The review in brief, machine-written

The main theorem is a genuinely new result: local existence and uniqueness of strong pathwise solutions for the random PDE-ODE glioma-treatment system from [1], including the OU-modulated radiotherapy terms. It is the first well-posedness statement for that particular model, and the proof is mostly careful: a priori estimates for v, Lipschitz and resolvent estimates, then a fixed point contraction in Y(T) using Yagi's framework. The authors also state the local-in-time limitation plainly and do not oversell global results.

The soft spots are real but not all equal. The most serious is an assumptions-versus-scope mismatch. Assumption II.2 contains |gamma_1T DM(x) gamma_0| < M~_D |gamma_1 . gamma_0| for all gamma_1, gamma_0. For orthogonal gamma_1, gamma_0 the right side is zero, so this forces DM(x)=c(x)I; with D1=0 in Assumption II.6, c is constant. Read literally, Theorem 3.2 covers homogeneous isotropic diffusion, not the anisotropic DTI tensors advertised in the abstract and introduction. If the cross-bound is a typo for a product of norms, the anisotropy objection mostly disappears, but D1=0 remains: the abstract operator enforces nu . D0 grad u = 0, which only matches the total no-flux condition (D1 u + D0 grad u) . nu = 0 when D1=0. The theorem is likely internally sound, but as stated it does not prove local well-posedness for the model that motivates the paper.

In Lemma 3.11 the contraction in the Z2,p component of Y(T) is asserted rather than displayed; that is a load-bearing step and should be written out. The resolvent lemma also has a negative-fractional-power notation that needs cleaning up, but that looks fixable.

I would send this to a referee with a request to fix the assumptions or rescope the claims. The analytic skeleton is credible, and if Assumption II.2 is a typo and the D1=0 restriction is acknowledged as a deliberate simplification, the paper becomes an honestly scoped local well-posedness result for a stochastic reaction-diffusion-taxis model with OU treatment noise. As it stands, the advertised anisotropy is not delivered.

The strongest objection

Assumption II.2 contains a cross-ellipticity estimate |γ_1^T D_M(x) γ_0| < M̃_D |γ_1·γ_0| for all γ_1,γ_0 ∈ R^n. Read literally, for γ_1 ⊥ γ_0 the right side is zero, so γ_1^T D_M γ_0 = 0 for every orthogonal pair. This forces D_M(x) = c(x) I: any genuinely anisotropic symmetric tensor has some orthonormal frame in which γ_1^T D_M γ_2 ≠ 0 while γ_1·γ_2 = 0. Combined with Assumption II.6 (D_1 = ∇·D_M = 0), the theorem as stated covers only D_M = const · I, i.e., homogeneous isotropic diffusion. The abstract and introduction advertise anisotropic DTI-derived tensors, and the original model (1) has D_1 = ∇·D_M ≠ 0 in general, so Theorem 3.2 does not deliver the advertised scope. If the dot product in II.2 is a typo for M̃_D |γ_1| |γ_0|, then the anisotropy objection disappears, but the D_1 = 0 restriction in II.6 remains: the abstract operator uses the domain ν·D_0∇u = 0, so an abstract solution does not enforce the total no-flux condition (D_1 u + D_0∇u)·ν = 0 unless D_1 = 0. The theorem may be internally sound under its stated assumptions; the load-bearing problem is that those assumptions no longer describe the model motivating the paper.

The reader's weakest assumption is the D_1 = 0 restriction, and I agree that it narrows the theorem; however, I find an even more severe narrowing in the literal text of Assumption II.2, which the reader did not flag. The cross-bound involving the dot product γ_1·γ_0 forces D_M to be scalar, and together with D_1 = 0 reduces the covered case to constant isotropic diffusion. If the dot product is a typo, the paper must correct it; if it is not, the theorem does not handle the anisotropic DTI tensors advertised in the abstract. In either case, the D_1 = 0 assumption removes the drift term ∇·(D_1 u) present in the original model (1). These are scope gaps rather than internal contradictions: the proof of Theorem 3.2 appears to follow Yagi's evolution-operator machinery with reasonable a priori estimates, and the explicit formula for v is independent support. The compressed W^{2,p} part of the Y-contraction in Lemma 3.11 is a place where the paper should add detail, but the fixed-point argument can be run in X(T), so I do not see a definite break of the central claim under the stated assumptions. The conditional verdict therefore stands, with the required revisions being to correct or justify II.2 and to either remove the D_1 = 0 restriction or explicitly state that the result concerns divergence-free, or constant scalar, diffusion tensors only.

The referee's report

If the proof is correct, the paper provides a first rigorous local well-posedness result for a stochastic multiscale glioma model with OU-modulated radiotherapy terms. The approach is constructive and uses standard tools: explicit solution of the OU process, pathwise moment and Hölder estimates, non-autonomous sectorial operator theory from Yagi's monograph, and a contraction mapping on a stochastic path space. The paper is careful about stating assumptions and gives detailed a priori estimates. However, the advertised scope is considerably narrowed by the stated assumptions: as written, Assumption II.2 forces the diffusion tensor to be scalar, and Assumption II.6 restricts to divergence-free tensors, so Theorem 3.2 does not cover the anisotropic DTI setting announced in the abstract and introduction. A second load-bearing issue is that the contraction estimate in Lemma 3.11 is asserted rather than fully displayed for the W^{2,p} component of the Y(T)-norm. These issues place the result in need of substantive revision rather than minor polishing.

Pith's reading of the paper (a machine's summary, not the authors')

This paper aims to prove that a recently proposed multiscale model of glioma invasion and radiotherapy is mathematically well posed. The model couples a reaction–diffusion–taxis PDE for the tumor density $u$ with an ODE for the healthy tissue density $v$, and lets the treatment terms be modulated by an Ornstein–Uhlenbeck noise process $\xi_t$ that captures day-to-day uncertainties in dose delivery. The central claim, Theorem 3.2, is that on a short time interval there exists exactly one solution pair $(u,v)$: the tumor equation holds pathwise for almost every noise realization, and the tissue density is given by an explicit exponential formula. A sympathetic reader should care because this is the first existence and uniqueness result for a stochastic continuum model of this kind, and well-posedness is the precondition for trusting simulations, uncertainty quantification, and therapy-outcome metrics built on the model. The authors state plainly that the result is local in time and that global existence remains open.

What carries the argument. The carrying mechanism is the semilinear non-autonomous reformulation of the tumor equation, $\frac{du}{dt}+A(w,v)u=F(u,v)$, in which $A(w,v)$ is a sectorial elliptic operator whose diffusion coefficient is frozen at the path $(w,v)$, together with the explicit pathwise solution of the healthy-tissue ODE and the explicit strong solution of the exponential Ornstein–Uhlenbeck process $\xi_t$. A priori estimates give $v\in[0,1]$, Hölder-in-time regularity for the tissue density and the radiation terms $R_M,R_Q$, and Lipschitz continuity of the map $w\mapsto v(w)$; these feed the resolvent and sectoriality estimates for $A$ and the Lipschitz bounds for $F$ required by the abstract parabolic existence theory. The solution map $\Phi(w)=u(w)$ is then shown to map the closed stochastic ball $Z(T^*)$ into itself and to contract for sufficiently small $T^*$, so the Banach fixed point theorem yields the unique local solution.

Core claim. On its own terms, the paper establishes local well-posedness of the macroscopic system (2): under Assumptions I and II on the initial data, coefficients, diffusion tensor, and treatment noise, there exists a time horizon $T^*\in(0,T]$ such that the system admits a unique pair $(u,v)$ with $u$ in the stochastic path space $X(T^*)$ and $v$ given explicitly by $v(t)=v_0\exp(-\int_0^t(\kappa_3\psi(u_s)+R_Q(\xi_s))\,ds)$ for almost every $\omega$. The equations are satisfied pathwise in the sense of Theorem 3.1, the tumor density stays nonnegative, and the normal tissue density stays in $[0,1]$. The strategy is to solve the normal-tissue ODE explicitly, freeze the resulting paths in the tumor operator, solve the tumor equation with non-autonomous evolution-operator theory, and close a contraction argument on a stochastic path space, so uniqueness holds in the strong, pathwise sense the analysis uses.

The premise it rests on. The proof depends on Assumption II.6, which requires $D_1=\nabla\cdot D_M=0$ together with boundary conditions $\nu\cdot(gD_M\nabla v_0)=0$ and $\nu\cdot(gD_M\nabla R_Q)=0$, so the theorem covers divergence-free diffusion tensors rather than the general anisotropic DTI-derived tensors the model's motivation advertises.

If the paper is right (Pith's inferences, not the authors')

On the existence horizon, numerical simulations of the stochastic treatment model are anchored: the computed tumor–tissue pair is the unique solution of the continuum problem, not an artifact of the discretization.

The invariant bounds persist wherever the local solution exists: tumor density stays nonnegative and healthy tissue density stays in $[0,1]$, keeping outputs in the biologically interpretable range.

Because $\Phi$ is a contraction, small changes in the initial data and radiation parameters produce controlled changes in the solution, the continuity needed for fitting the model to DTI and clinical data.

All randomness enters through the finite-dimensional Ornstein–Uhlenbeck process, so the pathwise framework applies without change to any Hölder-continuous treatment-noise model with the same moment bounds.

The theorem fixes the horizon $T^*$ only implicitly through the contraction constants, so determining how large $T^*$ can be, or extending to global existence, is the immediate open follow-up the authors flag.

The divergence-free restriction $D_1=\nabla\cdot D_M=0$ in Assumption II.6 means the theorem as stated does not cover the general anisotropic DTI tensors the model is motivated by; a plausible route around this is a change of variables or a reformulated boundary condition that absorbs $\nabla\cdot D_M$ into the flux.

Because the proof is a contraction, it implicitly yields a quantitative lower bound for the existence time $T^*$ in terms of the data norms; working out those constants would give the first explicit guarantee of how long a treatment simulation can be trusted.

The stochasticity is concentrated in a single Ornstein–Uhlenbeck process shared by both depletion terms, so the effective random dimension is one; replacing it by space-time noise would demand substantially new tools, a difficulty the authors themselves note.

The companion simulations show the deterministic trajectory staying near the stochastic mean while spreads grow with dose intensity; the well-posedness result is the prerequisite for asking at what noise level the deterministic mean stops being representative.

Check this review

Pith stored no record of this review's passes and took no fingerprint of it. Reviews made by code from 13 Nov 2026 on carry both.

How often reviews like this one are right

Reviews like this one: written by deepseek-v4-flash, where what was read was not recorded.

How often objections from reviews like this one are right: not yet measured

Every value above, in the review's public record (JSON)

Reviews by people

This review was written by a machine. No person has reviewed this paper on Pith yet. A scientist listed on Pith can review it for a fee, and their review is published here whatever it concludes.

Request a human review

How Pith checks papers · The full audit of this paper

The paper

Abstract

We study a stochastic model for the growth and invasion of glioma cells in the anisotropic brain tissue, also incorporating effects of radiotherapeutic interventions and associated uncertainties. The PDE-ODE model couples glioma and healthy tissue dynamics in a nonlinear manner and explicitly includes treatment-related stochasticity through random depletion terms. The macroscopic system has been obtained by an upscaling procedure from a microscopic description in [1]. We prove the existence and uniqueness of local strong solutions to the corresponding stochastic system. The analysis addresses challenges arising from the nonlinear coupling, anisotropic diffusion, taxis mechanisms, and stochastic treatment effects, providing a first rigorous step toward the mathematical understanding of stochastic continuum models for glioma invasion and therapy response.

The paper's own sentences, arranged, kept beside the review and separate from it. Each label is drawn from a closed vocabulary; the number beside it is the probability the classifier gave that label. No sentence in this record was written by a model.

abstract compiled · 2026-10-27

The authors' main claim, as the classifier picked it out 1.00

“We prove the existence and uniqueness of local strong solutions to the corresponding stochastic system.”

How the main claim is stated: asserted 1.00

What the abstract itself states, as probabilities: claims first 0.55 · states limitation 0.57 · human participants 0.08 · controlled comparison 0.03 · randomized assignment 0.02 · states quantitative result 0.05 · compares with prior results 0.09 · mentions code or data availability 0.01

The abstract, sentence by sentence

This table labels the abstract only (arXiv listing abstract v1). The number is the probability the classifier gave the label.

SentenceRoleThe authors' own workStates the main conclusionStrength
We study a stochastic model for the growth and invasion of glioma cells in the anisotropic brain tissue, also incorporating effects of radiotherapeutic interventions and associated uncertainties. contribution 0.91 0.83 0.04 asserted 0.97
The PDE-ODE model couples glioma and healthy tissue dynamics in a nonlinear manner and explicitly includes treatment-related stochasticity through random depletion terms. method 0.81 0.64 0.04 asserted 1.00
The macroscopic system has been obtained by an upscaling procedure from a microscopic description in [1]. background 0.65 0.21 0.02 asserted 1.00
We prove the existence and uniqueness of local strong solutions to the corresponding stochastic system. result 0.88 0.97 0.85 asserted 1.00
The analysis addresses challenges arising from the nonlinear coupling, anisotropic diffusion, taxis mechanisms, and stochastic treatment effects, providing a first rigorous step toward the mathematical understanding of stochastic continuum models for glioma invasion and therapy response. interpretation 0.63 0.90 0.42 asserted 0.98

What kind of paper the classifier reports this is: theoretical result 1.00 · evidence from proof or derivation 1.00

What was examined, and what was not

Sources read

  • arXiv listing abstract v1

Not examined

  • full text
  • figures and tables
  • references and citing sentences
  • relations to other papers

Levels run

  • P abstract

Not run

  • S sections
  • T body sentences
  • C citations
  • R cross-paper relations

How the labels were made

Compiled by classifier-1.13.0 via TypeSafe API, question bank abstract-p1-20260923, 2026-10-27: 1 request, 4,261 input tokens.

Every quoted sentence on this record is the authors'. Every label is from Pith's closed vocabulary, with the probability shown beside it. This record as JSON

Figures (2)
Figure 1 of the paper
Figure 1. Deterministic vs stochastic trajectories. Comparison of simulated tumor volume (VT ) evolution over time of the stochastic model (10 different trajectories in gray) and the deterministic model (red line) in the case of DT = 15, 30, 45, as indicated in the panels’ title. DT indicates the number of days during which the treatment is administered
Figure 2 of the paper
Figure 2. Mean and standard deviation for the stochastic model. Comparison of simulated tumor volume (VT ) evolution over time of the deterministic model (red line) and the mean (black star markers) and standard deviation (black error bars) obtained from 200 simulation of the stochastic model in the case of the DT = 15, 30, 45, as indicated in the panels’ title. DT indicates the number of days during which the treatment is administered. To facilitate the subsequent existence analysis, we introduce the following equivalent formulation of the macroscopic stochastic PDE system. Definition 2.1…

Figures are the authors', reproduced from the paper.

References (47)
  1. [1] M. Conte et al., “Randomness-aware multiscale models of glioma invasion and treatment”,Proceed- ings of the Royal Society A: Mathematical physical and engineering sciences2026,482, 20260118 on Pith
  2. [2] R. Rockne et al., “A mathematical model for brain tumor response to radiation therapy”,Journal of Mathematical Biology2009,58, 561–578 on Pith
  3. [3] K. R. Swanson et al., “Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology”,Cancer Research2011,71, 7366–7375. 38 on Pith
  4. [4] C. Engwer et al., “Effective equations for anisotropic glioma spread with proliferation: a multiscale approach and comparisons with previous settings”,Mathematical medicine and biology: a journal of the IMA2016,33, 435–459 on Pith
  5. [5] A. Hunt, C. Surulescu, “A multiscale modeling approach to glioma invasion with therapy”,Viet- nam Journal of Mathematics2017,45, 221–240 on Pith
  6. [6] M. Conte et al., “Modeling invasion patterns in the glioblastoma battlefield”,PLoS Computational Biology2021,17, e1008632 on Pith
  7. [7] M. Conte et al., “Mathematical modeling of glioma invasion and therapy approaches via kinetic theory of active particles”,Mathematical Models and Methods in Applied Sciences2023,33, 1009– 1051 on Pith
  8. [8] M. Wrensch et al., “Epidemiology of primary brain tumors: current concepts and review of the literature”,Neuro-Oncology2002,4, 278–299 on Pith
  9. [9] Q. T. Ostrom et al., “The epidemiology of glioma in adults: a “state of the science” review”, Neuro-Oncology2014,16, 896–913 on Pith
  10. [10] W. Wick et al., “Treatment of glioblastoma in adults”,Therapeutic advances in neurological dis- orders2018,11, 1756286418790452 on Pith
  11. [11] M. E. Berens, A. Giese, ““... those left behind.” Biology and oncology of invasive glioma cells”, Neoplasia1999,1, 208–219 on Pith
  12. [12] N. Bellomo et al., “Towards a mathematical theory of behavioral human crowds”,Mathematical Models and Methods in Applied Sciences2022,32, 321–358 on Pith
  13. [13] N. Bellomo,Modeling Complex Living Systems, Birkh¨ auser Boston,2008 on Pith
  14. [14] K. Painter, T. Hillen, “Mathematical modelling of glioma growth: the use of diffusion tensor imaging (DTI) data to predict the anisotropic pathways of cancer invasion”,Journal of Theoretical Biology2013,323, 25–39 on Pith
  15. [15] A. Swan et al., “A Patient-Specific Anisotropic Diffusion Model for Brain Tumour Spread”,Bul- letin of Mathematical Biology2017,80, 1259–1291 on Pith
  16. [16] C. Engwer et al., “Glioma follow white matter tracts: a multiscale DTI-based model”,Journal of Mathematical Biology2015,71, 551–582 on Pith
  17. [17] K. R. Swanson et al., “A quantitative model for differential motility of gliomas in grey and white matter”,Cell proliferation2000,33, 317–329 on Pith
  18. [18] H. L. Harpold et al., “The evolution of mathematical modeling of glioma proliferation and inva- sion”,Journal of Neuropathology & Experimental Neurology2007,66, 1–9 on Pith
  19. [19] V. Gondi, “Radiotherapy intensification for glioblastoma: enhancing the backbone of treatment”, Chinese Clinical Oncology2021,10, 39–39 on Pith
  20. [20] C. Nieder et al., “Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblas- toma multiforme”,Radiation Oncology Investigations: Clinical and Basic Research1999,7, 36– 41 on Pith
show 27 more
  1. [21] T. H. Beckham et al., “Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches”,Neuro-Oncology Practice2024,11, 266–274 on Pith
  2. [22] J.-C. Trone et al., “Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis”,Radiation Oncology2020,15, 145 on Pith
  3. [23] M. R. Junttila, F. J. De Sauvage, “Influence of tumour micro-environment heterogeneity on ther- apeutic response”,Nature2013,501, 346–354 on Pith
  4. [24] B. Segedin, P. Petric, “Uncertainties in target volume delineation in radiotherapy–are they relevant and what can we do about them?”,Radiology and Oncology2016,50, 254 on Pith
  5. [25] B. Winey, M. Bussiere, “Geometric and dosimetric uncertainties in intracranial stereotatctic treat- ments for multiple nonisocentric lesions”,Journal of Applied Clinical Medical Physics2014,15, 122–132 on Pith
  6. [26] S. A. Hiremath et al., “On a coupled SDE-PDE system modeling acid-mediated tumor invasion”, Discrete and Continuous Dynamical Systems-Series B2018,23, 2339–2369. 39 on Pith
  7. [27] S. A. Hiremath, C. Surulescu, “A stochastic model featuring acid-induced gaps during tumor progression”,Nonlinearity2016,29, 851 on Pith
  8. [28] D. Katsaounis et al., “Stochastic differential equation modelling of cancer cell migration and tissue invasion”,Journal of Mathematical Biology2023,87 on Pith
  9. [29] E. A. B. F. Lima et al., “Analysis and numerical solution of stochastic phase-field models of tumor growth”,Numerical Methods for Partial Differential Equations2014,31, 552–574 on Pith
  10. [30] S. Essarrout et al., “Quantifying uncertainty of a mathematical model of drug transport in tu- mors”,Mathematical Modeling and Computing2022,9, 567–578 on Pith
  11. [31] A. Yagi,Abstract Parabolic Evolution Equations and Their Applications, Springer,2009 on Pith
  12. [32] A. Pazy,Semigroups of Linear Operators and Applications to Partial Differential Equations, Springer New York,1983 on Pith
  13. [33] K. Engel, R. Nagel,One-Parameter Semigroups for Linear Evolution Equations, Springer,1999 on Pith
  14. [34] G. Da Prato, J. Zabczyk,Stochastic Equations in Infinite Dimensions, Cambridge University Press, Cambridge, UK,1992 on Pith
  15. [35] C. Pr´ evot, M. R¨ ockner,A Concise Course on Stochastic Partial Differential Equations, Springer, Berlin,2007 on Pith
  16. [36] B. Oksendal,Stochastic differential equations: an introduction with applications, Springer Science & Business Media,2013 on Pith
  17. [37] L. Hlatky et al., “Influence of time-dependent stochastic heterogeneity on the radiation response of a cell population”,Mathematical Biosciences1994,122, 201–220 on Pith
  18. [38] H. Badri, K. Leder, “Optimal treatment and stochastic modeling of heterogeneous tumors”,Biol- ogy Direct2016,11, 40 on Pith
  19. [39] J. F. Fowler, “The linear-quadratic formula and progress in fractionated radiotherapy”,The British Journal of Radiology1989,62, 679–694 on Pith
  20. [40] M. Joiner, A. V. der Kogel,Basic clinical radiobiology fourth edition, CRC press,2009 on Pith
  21. [41] J. O’Donoghue, “The response of tumours with Gompertzian growth characteristics to fractionated radiotherapy”,International Journal of Radiation Biology1997,72, 325–339 on Pith
  22. [42] T. E. Wheldon et al., “The linear-quadratic transformation of dose–volume histograms in frac- tionated radiotherapy”,Radiotherapy and Oncology1998,46, 285–295 on Pith
  23. [43] A. Zhigun, “The Malliavin derivative and compactness: application to a degenerate PDE-SDE coupling”,preprint arXiv:1609.014952016 on Pith
  24. [44] S. Hiremath, C. Surulescu, “A stochastic multiscale model for acid mediated cancer invasion”, Nonlinear Analysis: Real World Applications2015,22, 176–205 on Pith
  25. [45] J. Kroos et al., “SDE-driven modeling of phenotypically heterogeneous tumors: The influence of cancer cell stemness”,Discrete and Continuous Dynamical Systems - Series B2019,24, 4629 on Pith
  26. [46] D. Adams, L. Hedberg,Function Spaces and Potential Theory, Springer,1999 on Pith
  27. [47] P. Grisvard,Elliptic Problems in Nonsmooth Domains, Pitman Publishing Inc.,1985. 40 on Pith
Cited by 1 Pith paper

Challenges and discussion

Disagree with the review, or know something it missed? Leave a comment, or challenge this review formally: a challenge becomes a permanent entry in this paper's record, and its decision is published here.

No comments yet.

Sign in to comment